Literature DB >> 5463652

Pharmacokinetic evidence for saturable renal tubular reabsorption of riboflavin.

W J Jusko, G Levy.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5463652     DOI: 10.1002/jps.2600590608

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  16 in total

1.  Perspectives on the history and scientific contributions of Gerhard Levy.

Authors:  Ho-Leung Fung; William J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-09-24       Impact factor: 2.745

Review 2.  The phenomenon and rationale of marked dependence of drug concentration on blood sampling site. Implications in pharmacokinetics, pharmacodynamics, toxicology and therapeutics (Part II).

Authors:  W L Chiou
Journal:  Clin Pharmacokinet       Date:  1989-10       Impact factor: 6.447

3.  A population pharmacokinetic/pharmacodynamic analysis of regadenoson, an adenosine A2A-receptor agonist, in healthy male volunteers.

Authors:  Toufigh Gordi; Paul Frohna; Hai-Ling Sun; Andrew Wolff; Luiz Belardinelli; Hsiao Lieu
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

4.  Identification of riboflavin transport by MDCK cells using quantitative fluorescence video microscopy.

Authors:  R J Lowy; K R Spring
Journal:  J Membr Biol       Date:  1990-07       Impact factor: 1.843

5.  The effects of urine pH and plasma protein binding on the renal clearance of disopyramide.

Authors:  J L Cunningham; D D Shen; I Shudo; D L Azarnoff
Journal:  Clin Pharmacokinet       Date:  1977 Sep-Oct       Impact factor: 6.447

6.  Mechanistic models describing active renal reabsorption and secretion: a simulation-based study.

Authors:  Melanie A Felmlee; Rutwij A Dave; Marilyn E Morris
Journal:  AAPS J       Date:  2012-11-30       Impact factor: 4.009

Review 7.  A modern view of pharmacokinetics.

Authors:  J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1973-10

8.  Accumulation kinetics of drugs with nonlinear plasma protein and tissue binding characteristics.

Authors:  P J McNamara; J T Slattery; M Gibaldi; G Levy
Journal:  J Pharmacokinet Biopharm       Date:  1979-08

9.  Urine flow-dependence of theophylline renal clearance in man.

Authors:  D D Tang-Liu; T N Tozer; S Riegelman
Journal:  J Pharmacokinet Biopharm       Date:  1982-08

Review 10.  Pharmacokinetic considerations in clinical toxicology: clinical applications.

Authors:  Darren M Roberts; Nick A Buckley
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.